Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

fluorodopa F 18

The amino acid analog fluorodopa (FDOPA) labeled with fluorine F 18, a positron-emitting isotope, with potential tumor tracer property. Fluorine F 18 fluorodopa is able to cross the blood-brain barrier and is taken up by brain tumor cells. As uptake is higher in tumor cells, tumors may then be imaged using positron emission tomography (PET). Assessing tumor uptake of FDOPA may be beneficial for diagnosis, localization and in determining further treatment.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:3-(2-fluoro-(sup 18)F-4,5-dihydroxyphenyl)-L-alanine
6-(18F)fluoro-L-DOPA
fluorine F 18 fluorodopa
fluorine-18-fluoro-L-DOPA
fluorodopa (18F)
L-6-(18F)fluoro-DOPA
Abbreviation:(18F)FDOPA
18F-DOPA
18F-FDOPA
Chemical structure:L-tyrosine, 2-(fluoro-18F)-5-hydroxy-
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search